Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Eissing

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Clinical Pharmacokinetics|October 24, 2023
The Pharmacokinetics of the Nonsteroidal Mineralocorticoid Receptor Antagonist FinerenoneRoland Heinig, Thomas Eissing
Advances in Experimental Medicine and Biology|December 14, 2011
Multiscale mechanistic modeling in pharmaceutical research and developmentLars Kuepfer, Jörg Lippert, Thomas Eissing
Molecular Diagnosis & Therapy|February 23, 2012
Pharmacogenomics of codeine, morphine, and morphine-6-glucuronide: model-based analysis of the influence of CYP2D6 activity, UGT2B7 activity, renal impairment, and CYP3A4 inhibitionThomas Eissing, Jörg Lippert, Stefan Willmann
Mathematical Biosciences|July 25, 2014
A pharma perspective on the systems medicine and pharmacology of inflammationJulio Lahoz-Beneytez, Katrin Schnizler, Thomas Eissing
CPT: Pharmacometrics & Systems Pharmacology|October 2, 2018
A Quantitative Systems Pharmacology Kidney Model of Diabetes Associated Renal Hyperfiltration and the Effects of SGLT InhibitorsPavel Balazki, Stephan Schaller, Thomas Eissing, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 17, 2020
A Physiologically-Based Quantitative Systems Pharmacology Model of the Incretin Hormones GLP-1 and GIP and the DPP4 Inhibitor SitagliptinPavel Balazki, Stephan Schaller, Thomas Eissing, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 24, 2018
Applied Concepts in PBPK Modeling: How to Extend an Open Systems Pharmacology Model to the Special Population of Pregnant WomenAndré Dallmann, Juri Solodenko, Ibrahim Ince, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 12, 2026
Impact of Event-Related Treatment Modifications in Exposure-Response Analyses of Repeated Time-to-Event DataSebastiaan Camiel Goulooze, Nelleke Snelder, Thomas Eissing, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 9, 2017
A multiscale, model-based analysis of the multi-tissue interplay underlying blood glucose regulation in type I diabetesFederico Wadehn, Stephan Schaller, Thomas Eissing, et al.
Frontiers in Physiology|February 14, 2013
A detailed physiologically based model to simulate the pharmacokinetics and hormonal pharmacodynamics of enalapril on the circulating endocrine Renin-Angiotensin-aldosterone systemKarina Claassen, Stefan Willmann, Thomas Eissing, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Clinical Pharmacokinetics|October 24, 2023
The Pharmacokinetics of the Nonsteroidal Mineralocorticoid Receptor Antagonist FinerenoneRoland Heinig, Thomas Eissing
Advances in Experimental Medicine and Biology|December 14, 2011
Multiscale mechanistic modeling in pharmaceutical research and developmentLars Kuepfer, Jörg Lippert, Thomas Eissing
Molecular Diagnosis & Therapy|February 23, 2012
Pharmacogenomics of codeine, morphine, and morphine-6-glucuronide: model-based analysis of the influence of CYP2D6 activity, UGT2B7 activity, renal impairment, and CYP3A4 inhibitionThomas Eissing, Jörg Lippert, Stefan Willmann
Mathematical Biosciences|July 25, 2014
A pharma perspective on the systems medicine and pharmacology of inflammationJulio Lahoz-Beneytez, Katrin Schnizler, Thomas Eissing
CPT: Pharmacometrics & Systems Pharmacology|October 2, 2018
A Quantitative Systems Pharmacology Kidney Model of Diabetes Associated Renal Hyperfiltration and the Effects of SGLT InhibitorsPavel Balazki, Stephan Schaller, Thomas Eissing, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 17, 2020
A Physiologically-Based Quantitative Systems Pharmacology Model of the Incretin Hormones GLP-1 and GIP and the DPP4 Inhibitor SitagliptinPavel Balazki, Stephan Schaller, Thomas Eissing, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 24, 2018
Applied Concepts in PBPK Modeling: How to Extend an Open Systems Pharmacology Model to the Special Population of Pregnant WomenAndré Dallmann, Juri Solodenko, Ibrahim Ince, et al.
CPT: Pharmacometrics & Systems Pharmacology|March 12, 2026
Impact of Event-Related Treatment Modifications in Exposure-Response Analyses of Repeated Time-to-Event DataSebastiaan Camiel Goulooze, Nelleke Snelder, Thomas Eissing, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 9, 2017
A multiscale, model-based analysis of the multi-tissue interplay underlying blood glucose regulation in type I diabetesFederico Wadehn, Stephan Schaller, Thomas Eissing, et al.
Frontiers in Physiology|February 14, 2013
A detailed physiologically based model to simulate the pharmacokinetics and hormonal pharmacodynamics of enalapril on the circulating endocrine Renin-Angiotensin-aldosterone systemKarina Claassen, Stefan Willmann, Thomas Eissing, et al.
Pageof 5